✦ LIBER ✦

Validation of a diagnostic approach to exclude recurrent venous thromboembolism

✍ Scribed by G. LE GAL; M. J. KOVACS; M. CARRIER; K. DO; S. R. KAHN; P. S. WELLS; D. A. ANDERSON; I. CHAGNON; S. SOLYMOSS; M. CROWTHER; M. RIGHINI; A. PERRIER; R. H. WHITE; L. VICKARS; M. RODGER

Book ID: 109152879
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 166 KB
Volume: 7
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2009.03324.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hospital-Based Approach to the Managemen

Hospital-Based Approach to the Management of Venous Thromboembolism

✍ Frederick A. Anderson 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 126 KB

Use of different d-dimer levels to exclu

Use of different d-dimer levels to exclude venous thromboembolism depending on clinical pretest probability

✍ L.-A. Linkins; S. M. Bates; J. S. Ginsberg; C. Kearon 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Residual vein obstruction to predict the

Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis

✍ M. CARRIER; M. A. RODGER; P. S. WELLS; M. RIGHINI; G. LE GAL 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

Diagnostic and therapeutic approach to p

Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy

✍ C. O. Morrissey; P. G. Bardy; M. A. Slavin; M. R. Ananda-Rajah; S. C. Chen; S. W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

Diagnostic DHPLC Quality Assurance (DDQA

Diagnostic DHPLC Quality Assurance (DDQA): A collaborative approach to the generation of validated and standardized methods for DHPLC-based mutation screening in clinical genetics laboratories

✍ Els Schollen; Elisabeth Dequeker; Shirley McQuaid; Bruno Vankeirsbilck; Genevièv 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

Genetic testing in a clinical diagnostic environment must be subject to rigorous quality control procedures, in order to ensure consistency and accuracy of results. Denaturing high performance liquid chromatography (DHPLC) has become a standard prescreening tool for mutation detection, offering very